Skip to main content
DNA Labs India

Fibroblast Growth Factor (FGF2) Test

DNA Labs India | ISO 9001:2015 Certified

Fibroblast Growth Factor (FGF2) Test

Short Name: FGF2 Test

Also known as: Basic Fibroblast Growth Factor Test, bFGF Test, FGF-2 Blood Test, Fibroblast Growth Factor 2 Quantitative Test

Fibroblast Growth Factor (FGF2) Test test available at DNA Labs India for ₹25,000. Uses Immunoassay on Plasma (EDTA) samples. Results in Sample must be submitted by the 7th of the month. Reports are typically available 2–3 weeks after sample acceptance and will be shared via online portal, email, or WhatsApp.. Free home collection in 300+ cities across India.

Send-OutAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of the Fibroblast Growth Factor (FGF2) Test is to quantitatively measure the level of FGF2 protein in blood plasma. This measurement aids clinicians, particularly oncologists, in evaluating angiogenic activity associated with certain malignancies. The test serves as a supplementary biomarker that may assist in disease assessment, treatment monitoring, and clinical decision-making when interpreted alongside other diagnostic findings such as imaging, biopsy, and standard tumour markers.

Test Code
557
CPT Code
83520
ICD Code
R89.4
Price
₹25,000
Sample Type
Plasma (EDTA)
Result Time
Sample must be submitted by the 7th of the month. Reports are typically available 2–3 weeks after sample acceptance and will be shared via online portal, email, or WhatsApp.
Fasting Required
No
Method
Immunoassay
Step 1

Sample Collection

Ensure the mandatory Test Send Out Consent Form (Form 35) is duly filled and signed prior to sample collection. Inform your healthcare provider about any medications, supplements, or ongoing treatments, particularly anti-angiogenic therapies. No specific fasting is required unless advised by your physician.

Method: Venipuncture

Step 2

Laboratory Analysis

A trained phlebotomist will collect approximately 2 mL of blood from a vein in your arm into a Lavender Top (EDTA) tube. The procedure typically takes a few minutes and is similar to a routine blood draw.

Step 3

Report Delivery

The plasma will be separated from the blood within 6 hours of collection using a cold centrifuge and then frozen immediately. The sample must not be thawed at any point during storage or transport. Mild bruising at the puncture site may occur and typically resolves within a few days.

Timeline: Sample must be submitted by the 7th of the month. Reports are typically available 2–3 weeks after sample acceptance and will be shared via online portal, email, or WhatsApp.

Patient Instructions

1
Before the Test:Complete and sign the Test Send Out Consent Form (Form 35). Inform your doctor about any medications or treatments you are currently receiving. No specific fasting is required unless advised by your physician.
2
During the Test:A standard venipuncture will be performed to collect blood into an EDTA tube. The process typically takes less than 5 minutes and involves minimal discomfort.
3
After the Test:Apply gentle pressure to the puncture site with a cotton ball. Mild bruising may occur. Your plasma sample will be processed and frozen per protocol, then shipped to the reference laboratory.

About This Test

Who Should Get This Test

The primary purpose of the Fibroblast Growth Factor (FGF2) Test is to quantitatively measure the level of FGF2 protein in blood plasma. This measurement aids clinicians, particularly oncologists, in evaluating angiogenic activity associated with certain malignancies. The test serves as a supplementary biomarker that may assist in disease assessment, treatment monitoring, and clinical decision-making when interpreted alongside other diagnostic findings such as imaging, biopsy, and standard tumour markers.

How to Prepare

  • Fill and sign the Test Send Out Consent Form (Form 35) before sample collection — this is mandatory
  • Blood is collected in a Lavender Top (EDTA) tube (minimum 1 mL plasma required)
  • Plasma must be separated within 6 hours of collection using a cold centrifuge
  • Freeze the separated plasma immediately after centrifugation
  • DO NOT THAW the sample once frozen — ship frozen to the laboratory
  • Sample must be submitted by the 7th of the month for processing

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"FGF2 is a key mediator of angiogenesis and tumour growth. Elevated circulating FGF2 levels may indicate active disease in certain malignancies and can serve as a supplementary biomarker alongside standard tumour markers. This test is most valuable when interpreted within the full clinical context, including imaging and histopathology. Patients should discuss results with their treating oncologist to determine appropriate next steps."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypePlasma (EDTA)
Sample Volume2 mL (1 mL minimum)
ContainerLavender Top (EDTA) tube
Collection MethodVenipuncture

Sample Stability

Room Temperature
Refrigerated (2–8°C)
Frozen (-20°C or below)
Sample Rejection Criteria:
  • Hemolyzed samples
  • Thawed samples (once frozen, samples must not be thawed)
  • Missing or incomplete Test Send Out Consent Form (Form 35)
  • Insufficient sample volume (below 1 mL plasma)
  • Plasma not separated within 6 hours of collection
  • Samples not shipped in frozen condition

Understanding Your Results

The FGF2 test measures the circulating level of Fibroblast Growth Factor 2 in plasma. Results should always be interpreted by a qualified healthcare professional, ideally the referring oncologist, in conjunction with the patient's clinical history, imaging findings, and other laboratory results. Elevated FGF2 levels do not independently confirm a diagnosis but may support clinical assessment of angiogenic activity associated with certain conditions.
📊

FGF2 levels within the laboratory reference range suggest that circulating FGF2 is within expected physiological limits. This does not rule out all disease and should be interpreted with other clinical findings.

📊

Higher-than-reference FGF2 levels may indicate increased angiogenic activity. This has been observed in certain malignancies, cardiovascular conditions, and metabolic disorders such as diabetes. Elevated levels warrant further clinical evaluation by the treating physician or oncologist.

📊

Values near the upper limit of the reference range should be interpreted cautiously and may warrant repeat testing or correlation with additional biomarkers and clinical findings.

⚠️ When to Consult a Doctor:

Consult your oncologist or treating physician if your FGF2 levels are elevated, if results are inconsistent with your clinical picture, or if you have new or worsening symptoms. Elevated FGF2 may require further investigation with imaging, biopsy, or additional laboratory tests as directed by your healthcare provider.

Limitations

  • This is a send-out test; samples are batched and processed on a specific schedule (by the 7th of each month)
  • Results are available 2–3 weeks after sample acceptance, which may not be suitable for urgent clinical decisions
  • FGF2 levels should not be used as a standalone diagnostic marker for any malignancy
  • Reference ranges may vary between laboratories and should be interpreted in clinical context
  • The test does not provide information about the specific source or type of tumour

Risks & Considerations

  • Minor bruising or discomfort at the blood draw site
  • Rarely, slight swelling or infection at the puncture site
  • Fainting or dizziness during blood collection (uncommon)

Interfering Factors

  • Hemolyzed blood samples may interfere with accurate FGF2 measurement
  • Recent surgical procedures, trauma, or acute injury may transiently elevate FGF2 levels
  • Concurrent use of anti-angiogenic therapies may alter circulating FGF2 concentrations
  • Improper sample handling, including thawing after freezing, can compromise test accuracy
  • Delayed separation of plasma beyond the recommended 6-hour window may affect results
  • Lipemic or severely icteric samples may cause analytical interference

Compare With Similar Tests

TestFibroblast Growth Factor (FGF2) TestVEGF TestAFP (Alpha-Fetoprotein)CEA (Carcinoembryonic Antigen)
ComparisonFibroblast Growth Factor (FGF2) Test

Frequently Asked Questions

What is the Fibroblast Growth Factor (FGF2) Test?
The FGF2 Test is a specialised blood test that measures the level of Fibroblast Growth Factor 2 (also known as basic FGF or bFGF) in plasma. FGF2 is a protein involved in cell growth, tissue repair, and angiogenesis (formation of new blood vessels). It is used primarily as an oncology-related biomarker.
What is the cost of the FGF2 Test at DNA Labs India?
The Fibroblast Growth Factor (FGF2) Test at DNA Labs India is priced at INR 25000. This cost includes the test processing, consultation with our medical professionals, and free home sample collection in eligible cities across India.
What sample is required for the FGF2 Test?
The test requires 2 mL of blood (minimum 1 mL) collected in a Lavender Top (EDTA) tube. The plasma must be separated within 6 hours of collection using a cold centrifuge, frozen immediately, and shipped frozen. The sample must not be thawed at any point.
Is fasting required before the FGF2 Test?
No specific fasting is required for the FGF2 Test unless advised by your treating physician. However, the Test Send Out Consent Form (Form 35) must be duly filled and signed before sample collection.
How long does it take to get FGF2 Test results?
Samples must be submitted by the 7th of the month. Reports are typically available 2–3 weeks after sample acceptance. Results are delivered via online portal, email, or WhatsApp.
What conditions are associated with elevated FGF2 levels?
Elevated FGF2 levels have been associated with certain malignancies, cardiovascular conditions, and metabolic disorders such as diabetes. High FGF2 reflects increased angiogenic activity and should be interpreted by a qualified healthcare professional alongside other clinical findings.
Is home sample collection available for the FGF2 Test?
Yes, DNA Labs India offers free home sample collection for the FGF2 Test in major cities across India including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, and many more. Book online to schedule your home collection.
What is the methodology used for the FGF2 Test?
The FGF2 Test is performed using immunoassay methodology, which provides a quantitative measurement of FGF2 protein levels in plasma.
Is the Test Send Out Consent Form (Form 35) mandatory?
Yes, a duly filled and signed Test Send Out Consent Form (Form 35) is mandatory for the FGF2 Test. This is a send-out test, and the consent form is required before the sample can be collected and processed.
Can the FGF2 Test diagnose cancer on its own?
No, the FGF2 Test cannot diagnose cancer independently. It is a supplementary biomarker that provides information about angiogenic activity. Results must be interpreted by an oncologist or treating physician alongside imaging, biopsy, standard tumour markers, and the patient's complete clinical history.
What does a normal FGF2 level mean?
An FGF2 level within the laboratory reference range suggests that circulating FGF2 is within expected physiological limits. However, normal results do not rule out all disease conditions. Your doctor will interpret the results in the context of your overall clinical picture.
Are there any risks associated with the FGF2 Test?
The FGF2 Test involves a standard blood draw, which carries minimal risks such as minor bruising, slight discomfort at the puncture site, or rarely, dizziness. There are no significant risks beyond those of a routine venipuncture.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.